You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 112 No. 3, March 1994 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Role of Fat-Suppression Technique and Gadopentetate Dimeglumine in Magnetic Resonance Imaging Evaluation of Intraocular Tumors and Simulating Lesions

Patrick De Potter, MD; Adam E. Flanders, MD; Jerry A. Shields, MD; Carol L. Shields, MD; Carlos F. Gonzales, MD; Vijay M. Rao, MD

Arch Ophthalmol. 1994;112(3):340-348.


Abstract

Objective
Recent studies have shown that contrast (gadopentetate dimeglumine)-enhanced magnetic resonance imaging is useful in evaluating intraocular tumors and differentiating uveal melanoma from other simulating lesions. The purpose of this study was to study prospectively the role of fat-suppression technique and gadopentetate dimeglumine—enhanced magnetic resonance imaging in the evaluation of intraocular neoplasia.

Patients
Forty-three uveal melanomas and 20 other simulating intraocular lesions from 63 patients were prospectively evaluated on non-contrast-enhanced and post—contrast-enhanced T1-weighted images with and without fat-suppression technique and on T2--weighted images.

Results
Forty-one uveal melanomas (95%) were detected with standard pulse sequences and showed the characteristic hyperintense signal on non—contrast-enhanced T1-weighted images and hypointense signal with respect to the vitreous on T2-weighted images. All33 uveal melanomas evaluated on non—contrast-enhanced T1-weighted images with fat-suppression technique were detected on noncontrast-enhanced images with fat-suppression technique. The intensity of the signal was statistically associated with the degree of pigmentation of the tumor on T1-weighted images with fat-suppression technique (P=.03). On post-contrast-enhanced T1-weighted images with or without fat-suppression technique, the 43 uveal melanomas showed enhancement. The degree of tumor enhancement was not statistically related to the degree of tumor pigmentation or the location of the tumor. Among the other simulating intraocular lesions, choroidal metastasis, retinoblastoma, choroidal leiomyoma, and medulloepithelioma demonstrated the same features on magnetic resonance imaging studies as uveal melanoma demonstrated on non—contrast-enhanced and post—contrast-enhanced T1-weighted images with or without fat-suppression technique. In our series, choroidal hemangioma, choroidal osteoma, posterior scleritis, retinal hemangioma, and Coats' disease can be differentiated from other amelanotic intraocular tumors by their characteristics on magnetic resonance imaging studies.

Conclusions
We concluded that pre- and post-contrast-enhanced T1-weighted images with fat-suppression technique are most helpful in detecting small intraocular tumors with a thickness of more than 1.8 mm and in evaluating intraocular neoplasms and simulating lesions, particularly when T2-weighted images are not available. Moreover, in juxtapapillary choroidal or retinal tumor, fat-suppression technique may help in the detection of possible optic nerve or orbital extension by improving the conspicuousness of the tumor.



Author Affiliations

From the Ocular Oncology Service (Drs De Potter, J. A. Shields, and C. L. Shields), Wills Eye Hospital, and the Department of Radiology (Drs Flanders, Gonzales, and Rao), Thomas Jefferson University Hospital, Philadelphia, Pa.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Is CT Still Useful in the Study Protocol of Retinoblastoma?
Galluzzi et al.
Am. J. Neuroradiol. 2009;30:1760-1765.
ABSTRACT | FULL TEXT  

MR Imaging Findings of the Uveal Schwannoma
Xian et al.
Am. J. Neuroradiol. 2009;30:769-773.
ABSTRACT | FULL TEXT  

Retinoblastoma: MR Imaging Parameters in Detection of Tumor Extent
de Graaf et al.
Radiology 2005;235:197-207.
ABSTRACT | FULL TEXT  

Retinoblastoma: Abnormal Gadolinium Enhancement of Anterior Segment of Eyes at MR Imaging with Clinical and Histopathologic Correlation
Galluzzi et al.
Radiology 2003;228:683-690.
ABSTRACT | FULL TEXT  

High resolution magnetic resonance imaging of retinoblastoma
Schueler et al.
Br J Ophthalmol 2003;87:330-335.
ABSTRACT | FULL TEXT  

MR findings of malignant melanoma of the vagina
Fan et al.
Br. J. Radiol. 2001;74:445-447.
ABSTRACT | FULL TEXT  

Uveal Melanoma: Correlation of Histopathologic and Radiologic Findings by Using Thin-Section MR Imaging with a Surface Coil
Lemke et al.
Radiology 1999;210:775-783.
ABSTRACT | FULL TEXT  

Radiological Case of the Month
Mendivil and Cuartero
Arch Pediatr Adolesc Med 1997;151:1261-1262.
ABSTRACT  

Does the Melanin Content of Uveal Malignant Melanomas Correlate With Their Magnetic Resonance Imaging Appearance?-Reply
De Potter et al.
Arch Ophthalmol 1995;113:556-556.
ABSTRACT  

Does the Melanin Content of Uveal Malignant Melanomas Correlate With Their Magnetic Resonance Imaging Appearance?
Ferris and Bloom
Arch Ophthalmol 1995;113:555-556.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1994 American Medical Association. All Rights Reserved.